The present invention relates to the use of the quinazolinone compounds of the general formula (I) as vanilloids, in free or salt form, and possibly in acid addition salt form.n n n <Formula I>n n n n n n n n Wheren n n R 1 , R 2 , R 3 , R 4 , R 5 and m are as defined in the specification and claims.n n n Vanilloid, antagonist, quinazolinone, inflammatory disease